0001415889-24-019061.txt : 20240702
0001415889-24-019061.hdr.sgml : 20240702
20240702203355
ACCESSION NUMBER: 0001415889-24-019061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Desai Arjun JJ
CENTRAL INDEX KEY: 0001982985
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39813
FILM NUMBER: 241097970
MAIL ADDRESS:
STREET 1: C/O TRISALUS LIFE SCIENCES, INC.
STREET 2: 6272 W. 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TriSalus Life Sciences, Inc.
CENTRAL INDEX KEY: 0001826667
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 853009869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
BUSINESS PHONE: 415 336 8917
MAIL ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
FORMER COMPANY:
FORMER CONFORMED NAME: MedTech Acquisition Corp
DATE OF NAME CHANGE: 20200930
4
1
form4-07032024_120751.xml
X0508
4
2024-07-01
0001826667
TriSalus Life Sciences, Inc.
TLSI
0001982985
Desai Arjun JJ
6272 W. 91ST AVENUE
WESTMINSTER
CO
80031
true
false
false
false
0
Common Stock
2024-07-01
4
A
0
74000
A
277127
D
Redeemable Warrants
2024-07-01
4
D
0
246667
D
2020-12-17
Common Stock
246667
0
D
As previously disclosed, on May 24, 2024, TriSalus Life Sciences, Inc. (the "Issuer"), announced the commencement of its offer (the "Issuer Tender Offer") to all holders of each class of certain outstanding warrants (the "Warrants"), consisting of (a) the Issuer's publicly-traded Warrants currently listed on the Nasdaq Global Market under the symbol "TLSIW", (b) certain Warrants issued in a private placement transaction occurring simultaneously with the closing of the initial public offering of the Issuer and (c) certain Warrants issued for working capital requirements and payment of certain expenses of the Issuer, each identified in the Prospectus/Offer to Exchange that forms a part of the Issuer's Registration Statement on Form S-4 (Registration No. 333- 279691), filed with the Securities and Exchange Commission on May 24, 2024, to receive 0.3 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), [continued on footnote 2]
[continued from footnote 1] in exchange for each Warrant tendered by the holder and exchanged pursuant to the Issuer Tender Offer. Pursuant to the Issuer Tender Offer, the Reporting Person tendered 246,667 Warrants in exchange for 74,000 shares of Common Stock.
Represents Warrants received as a pro rata distribution for no consideration from MedTech Acquisition Sponsor LLC ("Sponsor") in accordance with the terms of the Sponsor's limited liability company agreement.
The Warrants expire on August 9, 2028, or earlier upon redemption or liquidation.
/s/ Sean Murphy, Attorney-in-Fact
2024-07-01